stockrowADMA Biologics Inc
ADMA Healthcare Biotechnology
ADMA Biologics Inc’s revenue for fiscal 2025 (year ended December 2025) was $510.2 million, up 19.6% from fiscal 2024.
- Revenue
- +5.12%
- EPS
- +46.7%
- Free cash flow
- +1,709.5%
- Total debt
- +140.5%
Quarter to September 2026, against a year earlier
Follow ADMA
Alert me
ADMA Biologics Inc (ADMA) Operating margin
ADMA Biologics Inc's operating margin over the twelve months to 30 September 2026 was 46.5%, up 8.9 percentage points from fiscal 2025 (37.5%). Over the past ten years it has ranged from −355.0% (fiscal 2018) to 37.5% (fiscal 2025) — the current reading is the highest in ten years. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 37.5% | 4.94 |
| FY2024 | 32.6% | 24.21 |
| FY2023 | 8.38% | 33.93 |
| FY2022 | −25.6% | 46.57 |
| FY2021 | −72.1% | 81.63 |
| FY2020 | −153.8% | (12.61) |
| FY2019 | −141.1% | 213.81 |
| FY2018 | −355.0% | (182.24) |
| FY2017 | −172.7% | (10.15) |
| FY2016 | −162.6% | 53.58 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 48.0% | 5.86 |
| Jun 2026 | 42.2% | (8.74) |
| Mar 2026 | 50.9% | 5.81 |
| Dec 2025 | 45.1% | 7.08 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ADMA ADMA Biologics Inc | 46.5% |
| AUPH Aurinia Pharmaceuticals Inc compare | 44.8% |
| VCEL Vericel Corporation compare | 8.32% |
| IMNM Immunome, Inc. compare | 0.00% |
| VERA Vera Therapeutics, Inc. compare | 0.00% |
| BHVN Biohaven Ltd. compare | 0.00% |
| PHVS Pharvaris N.V. compare | 0.00% |
| PVLA Palvella Therapeutics, Inc. compare | 0.00% |
| CLDX Celldex Therapeutics, Inc. compare | −36,733.8% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on ADMA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement